TLR2 and myelodysplastic syndrome: Enhanced TLR2 signaling has recently been implicated in MDS.15 Our data support a role for TLR2 signaling in the regulation of HSCs, with agonist exposure leading to expansion of HSCs in the bone marrow and spleen, but a reduction in HSC self-renewal.